Docetaxel, Doxorubicin and Cyclophosphamide Versus Vinorelbine and Capecitabine in Patients Not Sufficiently / Sufficiently Responding as Preoperative Treatment of Locally Advanced or Operable Primary Breast Cancer
Clinical trial NCT00544765 · COMPLETED
Trial details
- NCT number
- NCT00544765
- Sponsor
- GBG Forschungs GmbH
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2002-09-01
- Primary completion
- 2008-02-01
- Enrollment
- 2014
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.